Illumina to Provide Oligonucleotides for Very Large-Scale Genomics Study At Cold Spring Harbor Laboratory.
Illumina Inc. announced that it has signed a commercial agreement with Cold Spring Harbor Laboratory (CSHL) to provide nearly 100,000 longmer oligonucleotides (oligos) for a large-scale study designed to determine the mechanism of RNA interference (RNAi).
